相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Improved Virological Outcomes in British Columbia Concomitant with Decreasing Incidence of HIV Type 1 Drug Resistance Detection
Vikram S. Gill et al.
CLINICAL INFECTIOUS DISEASES (2010)
Virologic Response Differences Between African Americans and European Americans Initiating Highly Active Antiretroviral Therapy With Equal Access to care
Amy C. Weintrob et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2009)
Food Insecurity is Associated with Incomplete HIV RNA Suppression Among Homeless and Marginally Housed HIV-infected Individuals in San Francisco
Sheri D. Weiser et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2009)
Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries
Martin W. G. Brinkhof et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2008)
CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy
Nina Khanna et al.
CLINICAL INFECTIOUS DISEASES (2008)
Emergence of drug resistance in HIV type 1-infected patients after receipt of first-line highly active antiretroviral therapy: A systematic review of clinical trials
Ravindra Gupta et al.
CLINICAL INFECTIOUS DISEASES (2008)
Clinical outcome of HIV-infected anti retroviral-naive patients with discordant immunologic and virologic responses to highly active antiretroviral therapy
Ruimin Tan et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2008)
Increasing age at HIV seroconversion from 18 to 40 years is associated with favorable virologic and immunologic responses to HAART
Amy C. Weintrob et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2008)
Impact of neighborhood-level socioeconomic status on HIV disease progression in a universal health care setting
Ruth Joy et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2008)
The influence of psychosocial characteristics and race/ethnicity on the use, duration, and success of antiretroviral therapy
Brian Wells Pence et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2008)
Estimation of HIV incidence in the United States
H. Irene Hall et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Durability and outcome of initial antiretroviral treatments received during 2000-2005 by patients in the Swiss HIV Cohort Study
Thi Tuyet Nhung Vo et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Study suggests by that limitations of HAART can be explained genetic differences at two human loci
[Anonymous]
FUTURE VIROLOGY (2008)
CCL3L1-CCR5 genotype influences durability of immune recovery during antiretroviral therapy of HIV-1-infected individuals
Sunil K. Ahuja et al.
NATURE MEDICINE (2008)
Sex issues in HIV-1-infected persons during highly active antiretroviral therapy: A systematic review
Emanuele Nicastri et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Directly observed therapy programmes for anti-retroviral treatment amongst injection drug users in Vancouver: Access, adherence and outcomes
Mark W. Tyndall et al.
INTERNATIONAL JOURNAL OF DRUG POLICY (2007)
Sex differences in the clinical, immunological and virological parameters of HIV-infected patients treated with HAART
Julio Collazos et al.
AIDS (2007)
Superior virological response to boosted protease inhibitor-based highly active antiretroviral therapy in an observational treatment programme
E. Wood et al.
HIV MEDICINE (2007)
Mortality among participants in the multicenter AIDS cohort study and the women's interagency HIV study
Nancy A. Hessol et al.
CLINICAL INFECTIOUS DISEASES (2007)
Optimizing resource allocation in United States AIDS drug assistance programs
Benjamin P. Linas et al.
CLINICAL INFECTIOUS DISEASES (2006)
HIV incidence trends among white and African-American active duty United States army personnel (1986-2003)
Christian T. Bautista et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2006)
Determinants of progression to AIDS or death after HIV diagnosis, United States, 1996 to 2001
H. Irene Hall et al.
ANNALS OF EPIDEMIOLOGY (2006)
HIV treatment beliefs and sexual transmission risk behaviors among HIV positive men and women
Seth C. Kalichman et al.
JOURNAL OF BEHAVIORAL MEDICINE (2006)
Effectiveness of highly-active antiretroviral therapy by race/ethnicity
Michael J. Silverberg et al.
AIDS (2006)
Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort
Alexandra Calmy et al.
AIDS (2006)
Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment
L Ferradini et al.
LANCET (2006)
Effective therapy has altered the spectrum of cause-specific mortality following HIV seroconversion
C Smit et al.
AIDS (2006)
Temporal changes in the physical fitness of US Army recruits
Joseph J. Knapik et al.
SPORTS MEDICINE (2006)
Discordant immunologic and virologic responses to highly active antiretroviral therapy are associated with increased mortality and poor adherence to therapy
DM Moore et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2005)
Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/μL in HIV type 1-infected individuals receiving potent antiretroviral therapy
GR Kaufmann et al.
CLINICAL INFECTIOUS DISEASES (2005)
Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death:: a prospective cohort study
JAC Sterne et al.
LANCET (2005)
Efficacy of antiretroviral therapy programs in resource-poor settings: A meta-analysis of the published literature
LC Ivers et al.
CLINICAL INFECTIOUS DISEASES (2005)
Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy.: Aquitaine Cohort, France, 1996-2002
F Bonnet et al.
HIV MEDICINE (2005)
Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003
HB Krentz et al.
HIV MEDICINE (2005)
Perspectives on adherence and simplicity for HIV-infected patients on antiretroviral therapy - Self-report of the relative importance of multiple attributes of highly active Antiretroviral therapy (HAART) regimens in predicting adherence
VE Stone et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2004)
Factors influencing medication adherence beliefs and self-efficacy in persons naive to antiretroviral therapy: A multicenter, cross-sectional study
NR Reynolds et al.
AIDS AND BEHAVIOR (2004)
Syphilis increases HIV viral load and decreases CD4 cell counts in HIV-infected patients with new syphilis infections
K Buchacz et al.
AIDS (2004)
Diverse HIV-1 subtypes and clinical, laboratory and behavioral factors in a recently infected US military cohort
SK Brodine et al.
AIDS (2003)
When to begin highly active antiretroviral therapy?: Evidence supporting initiation of therapy at CD4+ lymphocyte counts <350 cells/μL
JE Kaplan et al.
CLINICAL INFECTIOUS DISEASES (2003)
Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy
PW Hunt et al.
AIDS (2003)
HIV treatment adherence and unprotected sex practices in people receiving antiretroviral therapy
SC Kalichman et al.
SEXUALLY TRANSMITTED INFECTIONS (2003)
Socioeconomic status, access to triple therapy, and survival from HIV disease since 1996
E Wood et al.
AIDS (2002)
Risk of progression to AIDS and death in women infected with HIV-1 initiating highly active antiretroviral treatment at different stages of disease
K Anastos et al.
ARCHIVES OF INTERNAL MEDICINE (2002)
Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy:: a collaborative analysis of prospective studies
M Egger et al.
LANCET (2002)
Predictors of virological rebound in HIV-1-infected patients initiating a protease inhibitor-containing regimen
V Le Moing et al.
AIDS (2002)
HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load
AN Phillips et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG Adherence Instruments
MA Chesney et al.
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV (2000)
Long-term immunological response in HIV-1-infected subjects receiving potent antiretroviral therapy
GR Kaufmann et al.
AIDS (2000)
Predictors of virological success and ensuing failure in HIV-positive patients starting highly active antiretroviral therapy in Europe -: Results from the EuroSIDA Study
R Paredes et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
Factors associated with clinical and virological failure in patients receiving a triple therapy including a protease inhibitor
S Grabar et al.
AIDS (2000)
分享论文
